Ikarian Capital »

Pharvaris N V shares owned by Ikarian Capital

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 210k 24.95

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Bain Capital Life Sciences Investors
Deerfield Management Company
Commodore Capital
Paradigm Biocapital Advisors
Novo A/S
Wellington Management Company
Cormorant Asset Management
Saturn V Capital Management
5AM Venture Management

View all funds holding Pharvaris N V